Skip to main content

Special Reports Archive

  • Unilever turns heads with Dollar Shave club acquisition, extending reach in male grooming category

    Unilever’s $1 billion purchase of Dollar Shave Club was an eye-opening deal. While Unilever has been on a buying spree, snapping up companies such as REN, Kate Somerville, Dermalogica and Murad — all premium skin care brands — the deal with Dollar Shave represented growth in a different market. Now the industry awaits Unilever’s next move.

    (To view the full Shave Report, click here.)

  • J&J showcases new diabetes approach

    The front-end opportunity surrounding patients with diabetes is significant. Diabetes patients are spending between $1,000 and $2,500 each year on diabetes supplies alone, noted Sally Manoufar, senior manager health and wellness at Johnson & Johnson, during a recent GMDC webcast. According to Johnson & Johnson research, the front-end basket of a diabetes patient is five times larger than that of a patient who doesn’t have diabetes.

  • Moving beyond disease state management

    Walmart’s Annie Walker

    How can retailers and manufacturers work together to not only be partners in managing consumers’ disease states, but also to help educate a new generation about the importance of prevention? This was the driving question a panel of leading consumer health executives tackled in June, at a special one-day thought leadership conference in Bentonville, Ark., co-hosted by Drug Store News and Mack Elevation Forum.

  • Nexium 24HR remains leader ahead of private-label launches

    Pfizer’s Nexium 24HR is the clear leader in the digestive aisle. However, in March 2017, store-brand versions of Nexium 24HR will be available. Perrigo has already secured a tentative approval from the Food and Drug Administration for its OTC Nexium 24HR generic equivalent. “We are currently working with our retail customers in making plans to launch the item as soon as possible after the late March 2017 market exclusivity period expires for the national brand,” John Henderickson, Perrigo president and CEO, recently told investors.

  • Ferris: Access is main barrier to addressing eye health

    One disconnect Bausch + Lomb’s John Ferris sees in the conversation about health care is the relative lack of attention paid to eye health — even though age-related macular degeneration affects two-and-a-half times more people than Alzheimer’s disease, and baby boomers are as concerned about vision loss as contracting heart disease and cancer.

  • Aetna’s Speck touts humanizing health care

    Christina Speck, senior director of consumer initiatives at Aetna

    Successfully offering consumer-centric health care requires a multi-pronged approach that meets the needs of a wide variety of customer groups, Aetna senior director of consumer initiatives Christina Speck stressed at the recent Retail Health Summit.

  • Tech capitalizes on growing opportunities

    By now, the retail pharmacy industry knows that its place within the American healthcare landscape is changing. PricewaterhouseCoopers’ Health Research Institute has dubbed it the New Health Economy, and in May the firm highlighted the factors that are playing a key role in pharmacy’s transformation.

  • VoicePort looks toward comprehensive offerings with CLARO

    VoicePort arrived in Boston for the National Association of Chain Drug Stores’ Total Store Expo this year with a new name for its suite of pharmacy technology offerings. The company rebranded its PharmaPhonetics property as CLARO Pharmacy Solutions — a name change aimed at highlighting the growth the company’s offerings have seen since starting out in 2003, according to VoicePort VP North American business development Alphonse J. Sasso.

X
This ad will auto-close in 10 seconds